BAEUERLE PATRICK A ET AL: "Bispecific T-cell engaging antibodies for cancer therapy", CANCER RESEARCH, AACR, US PHILADELPHIA, PA, vol. 69, no. 12, 15 June 2009 (2009-06-15) , pages 4941-4944, XP002665118, ISSN: 1538-7445, DOI: 10.1158/0008-5472.CAN-09-0547 [retrieved on 2009-06-09] (B1)

CHAMES PATRICK ET AL: "Bispecific antibodies for cancer therapy. The light at the end of the tunnel?", MABS, LANDES BIOSCIENCE, US, vol. 1, no. 6, 1 November 2009 (2009-11-01), pages 539-547, XP002688758, ISSN: 1942-0862, DOI: 10.4161/MABS.1.6.10015 (B1)

CHAO M P ET AL: "CD47 IS AN ADVERSE PROGNOSTIC FACTOR IN NON-HODGKIN LYMPHOMA AND A THERAPEUTIC ANTIBODY TARGET THAT SYNERGIZES WITH RITUXIMAB", EXPERIMENTAL HEMATOLOGY (NEW YORK), vol. 37, no. 9, Suppl. 1, 9 September 2009 (2009-09-09), - 12 September 2009 (2009-09-12), pages S8-S9, XP009168476, & 38TH ANNUAL SCIENTIFIC MEETING OF THE ISEH-SOCIETY-FOR-HEMATOLOGY-AND-STEM-CELLS ; ATHENS, GREECE; SEPTEMBER 09 -12, 2009 ISSN: 0301-472X (B1)

CHAO MARK P ET AL: "Therapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B-Cell Lymphoma Xenografts", BLOOD, vol. 114, no. 22, November 2009 (2009-11), pages 1063-1064, XP009168477, & 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009 (B1)

DAFNE MÜLLER AND ROLAND KONTERMANN ED - STEFAN DÜBEL: "Handbook of Therapeutic antibodies; Part III, Chapter 2 :Bispecific Antibodies", 1 February 2008 (2008-02-01), HANDBOOK OF THERAPEUTIC ANTIBODIES, WILEY-VCH, WEINHEIM, PAGE(S) 352 - 378, XP002541368, ISBN: 978-3-527-31453-9 (B1)

ELIE DHEILLY ET AL: "Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies", MOLECULAR THERAPY, vol. 25, no. 2, 1 February 2017 (2017-02-01), pages 523-533, XP055407335, US ISSN: 1525-0016, DOI: 10.1016/j.ymthe.2016.11.006 (B1)

WO-A1-2009/091601 (B1)

US-A1- 2007 041 981 (B1)

US-A1- 2008 107 654 (B1)

US-A1- 2009 191 202 (B1)

WO-A1-2008/121821 (B1)

WO-A1-2009/091547 (B1)

EMILY C PICCIONE ET AL: "A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells", MABS, vol. 7, no. 5, 17 June 2015 (2015-06-17), pages 946-956, XP055314609, US ISSN: 1942-0862, DOI: 10.1080/19420862.2015.1062192 (B1)